Interferon: a cytotoxic T lymphocyte differentiation signal. 1986

L K Chen, and B Tourvieille, and G F Burns, and F H Bach, and D Mathieu-Mahul, and M Sasportes, and A Bensussan

Human T cell clones which were able to proliferate in response to specific stimuli but could not kill even in the presence of lectins were found to acquire the specific lytic function when interferon alpha or gamma was added on day 1 of the 7-day restimulation culture. These results demonstrate that interferon may act as a cytotoxic T lymphocyte differentiation signal. This signal can be blocked by the monoclonal antibody LeoA1 which recognizes a 70-kDa cell surface structure, involved in cytotoxic T lymphocyte differentiation.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic

Related Publications

L K Chen, and B Tourvieille, and G F Burns, and F H Bach, and D Mathieu-Mahul, and M Sasportes, and A Bensussan
July 1988, Biochimie,
L K Chen, and B Tourvieille, and G F Burns, and F H Bach, and D Mathieu-Mahul, and M Sasportes, and A Bensussan
September 1999, Transplantation,
L K Chen, and B Tourvieille, and G F Burns, and F H Bach, and D Mathieu-Mahul, and M Sasportes, and A Bensussan
October 1985, The Journal of experimental medicine,
L K Chen, and B Tourvieille, and G F Burns, and F H Bach, and D Mathieu-Mahul, and M Sasportes, and A Bensussan
May 1980, Nature,
L K Chen, and B Tourvieille, and G F Burns, and F H Bach, and D Mathieu-Mahul, and M Sasportes, and A Bensussan
May 2000, The Journal of experimental medicine,
L K Chen, and B Tourvieille, and G F Burns, and F H Bach, and D Mathieu-Mahul, and M Sasportes, and A Bensussan
January 1979, Annals of the New York Academy of Sciences,
L K Chen, and B Tourvieille, and G F Burns, and F H Bach, and D Mathieu-Mahul, and M Sasportes, and A Bensussan
October 2017, Cell death and differentiation,
L K Chen, and B Tourvieille, and G F Burns, and F H Bach, and D Mathieu-Mahul, and M Sasportes, and A Bensussan
February 1995, Transplantation proceedings,
L K Chen, and B Tourvieille, and G F Burns, and F H Bach, and D Mathieu-Mahul, and M Sasportes, and A Bensussan
March 1986, Journal of immunology (Baltimore, Md. : 1950),
L K Chen, and B Tourvieille, and G F Burns, and F H Bach, and D Mathieu-Mahul, and M Sasportes, and A Bensussan
April 2023, Experimental and therapeutic medicine,
Copied contents to your clipboard!